Floatz logo

Calcium folinate pentahydrate

Esophageal Squamous Cell Carcinoma

Neonc Technologies, Inc.Small moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Esophageal Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
AstraZeneca
Phase 3BB
Cyclophosphamide
Rondo Therapeutics
Phase 3B
Pembrolizumab
GV20 Therapeutics
Phase 3B
Epirubicin
Rondo Therapeutics
Phase 3B
CIS-DIAMMINEDICHLOROPLATINUM II
AstraZeneca
Phase 3B

View all 50 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →